Advanced Solid Tumors
Showing NaN - NaN of 68
Advanced Solid Tumors Trial in Worldwide (AMG 650)
Active, not recruiting
- Advanced Solid Tumors
- AMG 650
-
Los Angeles, California
- +21 more
Jan 26, 2023
Advanced Solid Tumors Trial in Worldwide (ASP1948, nivolumab, pembrolizumab)
Active, not recruiting
- Advanced Solid Tumors
- ASP1948
- +2 more
-
New Haven, Connecticut
- +41 more
Jan 10, 2023
Advanced Solid Tumors, Kirsten Rat Sarcoma (KRAS) pG12C Mutation Trial in Worldwide (Sotorasib, AMG 404, trametinib)
Recruiting
- Advanced Solid Tumors
- Kirsten Rat Sarcoma (KRAS) pG12C Mutation
- Sotorasib
- +15 more
-
Tucson, Arizona
- +83 more
Dec 28, 2022
NSCLC (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC) Trial in United States (RMC-6236)
Recruiting
- Non-small Cell Lung Cancer (NSCLC)
- +3 more
-
Boston, Massachusetts
- +9 more
Dec 22, 2022
Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors Trial in United States (Crizotinib, Palbociclib, Sunitinib)
Recruiting
- Lymphoma, Non-Hodgkin
- +2 more
- Crizotinib
- +17 more
-
Birmingham, Alabama
- +125 more
Nov 21, 2022
Advanced Solid Tumors Trial in Worldwide (AMG 994, AMG 404)
Active, not recruiting
- Advanced Solid Tumors
- AMG 994
- AMG 404
-
Duarte, California
- +16 more
Nov 16, 2022
Advanced Solid Tumors Trial in Worldwide (INCB081776, INCMGA00012)
Recruiting
- Advanced Solid Tumors
-
New Haven, Connecticut
- +19 more
Nov 10, 2022
Advanced Malignancy, Advanced Solid Tumors, Cancer Trial in United States (AMG 337)
Completed
- Advanced Malignancy
- +5 more
- AMG 337
-
Los Angeles, California
- +7 more
Nov 3, 2022
Advanced Solid Tumors Trial in United States (mRNA-4359, Pembrolizumab)
Recruiting
- Advanced Solid Tumors
- mRNA-4359
- Pembrolizumab
-
San Francisco, California
- +9 more
Sep 7, 2022
Advanced Solid Tumors Trial in Worldwide (Quavonlimab, Pembrolizumab, Pembrolizumab/Quavonlimab)
Active, not recruiting
- Advanced Solid Tumors
- Quavonlimab
- +2 more
-
Gilbert, Arizona
- +52 more
Aug 18, 2022
Advanced Solid Tumors, Squamous Cell Carcinoma of the Head and Neck (SCCHN), Gastrointestinal (GI) Malignancies Trial in
Recruiting
- Advanced Solid Tumors
- +2 more
- INCA00186
- +2 more
-
Los Angeles, California
- +31 more
Jul 20, 2022
Advanced Solid Tumors Trial in United States (ARRY-382, Pembrolizumab)
Terminated
- Advanced Solid Tumors
-
Los Angeles, California
- +29 more
May 21, 2022
Advanced Solid Tumors Trial in United States (FF-10832 Gemcitabine Liposome Injection)
Recruiting
- Advanced Solid Tumors
- FF-10832 Gemcitabine Liposome Injection
-
Scottsdale, Arizona
- +4 more
Apr 7, 2022
Advanced Solid Tumors Trial in United States (paclitaxel, FOLFIRI, ABT-165)
Active, not recruiting
- Advanced Solid Tumors
- paclitaxel
- +3 more
-
Scottsdale, Arizona
- +9 more
Mar 23, 2022
Advanced Solid Tumors, Head Neck Cancer, Pancreatic Cancer Trial in United States (Cabiralizumab, Nivolumab)
Completed
- Advanced Solid Tumors
- +6 more
- Cabiralizumab
- Nivolumab
-
Scottsdale, Arizona
- +38 more
Jan 5, 2022
Advanced Solid Tumors Trial in Nashville (X-82)
Completed
- Advanced Solid Tumors
-
Nashville, TennesseeSarah Cannon Research Institute
Feb 9, 2022
Advanced Solid Tumors Trial in France, United States (IPH5401 and Durvalumab)
Terminated
- Advanced Solid Tumors
- IPH5401 and Durvalumab
-
Louisville, Kentucky
- +11 more
Jan 12, 2022